Animal models of attention-deficit hyperactivity disorder

被引:164
作者
Davids, E
Zhang, KH
Tarazi, FI
Baldessarini, RJ
机构
[1] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02178 USA
[2] Harvard Univ, Sch Med, Neurosci Program, Belmont, MA 02178 USA
[3] Massachusetts Gen Hosp, Mailman Res Ctr, McLean Div, Belmont, MA 02178 USA
[4] Univ Essen Gesamthsch, Dept Psychiat & Psychotherapy, Essen, Germany
基金
美国国家卫生研究院;
关键词
attention deficit-hyperactivity disorder; behavior; dopamine; hyperactivity; norepinephrine; serotonin; stimulants;
D O I
10.1016/S0165-0173(02)00274-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Attention-deficit hyperactivity disorder (ADHD) involves clinically heterogeneous dysfunctions of sustained attention, with behavioral overactivity and impulsivity, of juvenile onset. Experimental models, in addition to mimicking syndromal features, should resemble the clinical condition in pathophysiology, and predict potential new treatments. One of the most extensively evaluated animal models of ADHD is the spontaneously hypertensive rat. Other models include additional genetic variants (dopamine transporter gene knock-out mouse, coloboma mouse, Naples hyperexcitable rat, acallosal mouse, hyposexual rat, and population-extreme rodents), neonatal lesioning of dopamine neurons with 6-hydroxydopamine, and exposure to other neurotoxins or hippocampal irradiation. None is fully comparable to clinical ADHD. The pathophysiology involved varies, including both deficient and excessive dopaminergic functioning, and probable involvement of other monoamine neurotransmitters. Improved models as well as further testing of their ability to predict treatment responses are required. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 21
页数:21
相关论文
共 314 条
  • [31] Cerebellum in attention-deficit hyperactivity disorder - A morphometric MRI study
    Berquin, PC
    Giedd, JN
    Jacobsen, LK
    Hamburger, SD
    Krain, AL
    Rapoport, JL
    Castellanos, FX
    [J]. NEUROLOGY, 1998, 50 (04) : 1087 - 1093
  • [32] Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder
    Biederman, J
    Spencer, T
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 46 (09) : 1234 - 1242
  • [33] Biederman J, 2000, EUR CHILD ADOLES PSY, V9, P51
  • [34] BLANCHARD V, 1995, J NEUROCHEM, V64, P1669
  • [35] Galanin microinjected into the medial preoptic nucleus facilitates female- and male-typical sexual behaviors in the female rat
    Bloch, GJ
    Butler, PC
    Kohlert, JG
    [J]. PHYSIOLOGY & BEHAVIOR, 1996, 59 (06) : 1147 - 1154
  • [36] Chronic L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder
    Boix, F
    Qiao, SW
    Kolpus, T
    Sagvolden, T
    [J]. BEHAVIOURAL BRAIN RESEARCH, 1998, 94 (01) : 153 - 162
  • [37] Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter
    Bosse, R
    Fumagalli, F
    Jaber, M
    Giros, B
    Gainetdinov, RR
    Wetsel, WC
    Missale, C
    Caron, MG
    [J]. NEURON, 1997, 19 (01) : 127 - 138
  • [38] Biological contributions to the presentation and understanding of attention-deficit/hyperactivity disorder: A review
    Bradley, JDD
    Golden, CJ
    [J]. CLINICAL PSYCHOLOGY REVIEW, 2001, 21 (06) : 907 - 929
  • [39] BREESE GR, 1987, J PHARMACOL EXP THER, V240, P167
  • [40] BREESE GR, 1984, J PHARMACOL EXP THER, V231, P343